not bad...after being down initially....before guidance.
Well...so it turned out that the good news we got this weekend was the cure of Jimmy Carter's melanoma by Keytruda, an immunotherapy from the "other Merck". Who knew?
....not sure what they could have done differently. Stock headed to $0.90